Narrow search
Showing 1 - 10 of 1,169
Cover Image
Leading Pharmaceutical Innovation : Trends and Drivers for Growth in the Pharmaceutical Industry
Gassmann, Oliver (contributor);  … - 2008 - Second Edition
Persistent link: https://www.econbiz.de/10013520901
Cover Image
The Chemical and Pharmaceutical Industry in China : Opportunities and Threats for Foreign Companies
Festel, Gunter; Oels, Udo; Kreimeyer, Andreas; Zedtwitz, Max - 2005
Persistent link: https://www.econbiz.de/10013520463
Cover Image
Business Process Management within Chemical and Pharmaceutical Industries : Markets, BPM Methodology and Process Examples
Grüne, Guido - 2014
As business processes are crucial success factors for companies, software-based Business Process Management (BPM) is becoming more and more important. In this area SAP, the market leader for enterprise application software, has already gathered substantial experience. For the characterization,...
Persistent link: https://www.econbiz.de/10014017133
Cover Image
Leading Pharmaceutical Operational Excellence : Outstanding Practices and Cases
Friedli, Thomas - 2013
Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model...
Persistent link: https://www.econbiz.de/10014017144
Cover Image
Strategisches Nachhaltigkeits-management in der pharmazeutischen Industrie : Eine empirische Untersuchung
Eckelmann, Oliver (contributor) - 2006
öffentliche Diskussion über Rolle und Verantwortung der Pharmaindustrie. Die Unternehmensverantwortlichen müssen sich daher mit … Nachhaltigkeit für die Pharmaindustrie. Er zeigt, dass die aktuellen Nachhaltigkeitsprobleme aufgrund unterschiedlicher Zusammenhänge …
Persistent link: https://www.econbiz.de/10013516620
Cover Image
Der Patentauslauf von Pharmazeutika als Herausforderung beim Management des Produktlebenszyklus
Raasch, Christina - 2010 - 2., durchgesehene und korrigierte Auflage
-- Auswirkungen von Patentausläufen in der pharmazeutischen Industrie -- Die Arbeitsweise von Marketing und Vertrieb in der … Patentauslaufstrategie und ihre Umsetzung in den Bereichen Marketing und Vertrieb bestimmend. Christina Raasch entwickelt eine umfassende …
Persistent link: https://www.econbiz.de/10013517082
Cover Image
Risk-sharing in the Pharmaceutical Industry : The Case of Out-licensing
Reepmeyer, Gerrit (contributor) - 2006
Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...
Persistent link: https://www.econbiz.de/10013520588
Cover Image
Erfolgreich im Pharma-Marketing : Wie Sie im Produktmanagement von Arzneimitteln Ärzte, Apotheker, Patienten, Experten und Manager als Kunden gewinnen
Umbach, Günter - 2011
Synergien zwischen Medizin und Marketing ausschöpft. Eine Vielzahl von anschaulichen Beispielen, Fallstudien und Tipps zum …
Persistent link: https://www.econbiz.de/10014425278
Cover Image
Use of Market Data in the Recruitment of High Potentials : Segmentation and Targeting in Human Resources in the Pharmaceutical Industry
Posthumus, Jan - 2015
Management and Identification of High Potentials.- Marketing Concepts -- Marketing within Human Resources.- Market …In his study, Jan Posthumus uses the grounded theory method to explore the implementation of marketing instruments such …. Contents Management and Identification of High Potentials Marketing Concepts Marketing within Human Resources Market Research …
Persistent link: https://www.econbiz.de/10014020121
Cover Image
Leading pharmaceutical innovation : how to win the life science race
Gassmann, Oliver; Schuhmacher, Alexander; Zedtwitz, … - 2018 - Third edition
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management...
Persistent link: https://www.econbiz.de/10012397599